Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Newly Diagnosed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05900882
What this trial is testing

SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease

Who this might be right for
Multiple Myeloma
The First Affiliated Hospital with Nanjing Medical University 29
Early research (Phase 1)Not Yet RecruitingNCT07114432
What this trial is testing

RN1201 Injection in Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma

Who this might be right for
Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma Patients Ineligible or Unwilling to Undergo ASCTNewly Diagnosed Multiple Myeloma (NDMM)
Tianjin Medical University Cancer Institute and Hospital 19
Large-scale testing (Phase 3)Active Not RecruitingNCT05317416
What this trial is testing

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

Who this might be right for
Multiple Myeloma
Pfizer 854
Testing effectiveness (Phase 2)Ended earlyNCT01969565
What this trial is testing

Study of Carfilzomib in Combination w/Dexamethasone in Patients w/Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Emory University 1
Large-scale testing (Phase 3)Study completedNCT01818752
What this trial is testing

Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Amgen 955
Testing effectiveness (Phase 2)Looking for participantsNCT05828511
What this trial is testing

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

Who this might be right for
Multiple Myeloma
Regeneron Pharmaceuticals 149
Not applicableNot Yet RecruitingNCT07746232
What this trial is testing

Validating DW-MRI and Fat Fraction in Multiple Myeloma Post-ASCT: The RAC-FAT Study"

Who this might be right for
Multiple Myeloma (MM)
Fondazione EMN Italy Onlus 92
Very early researchLooking for participantsNCT06407947
What this trial is testing

Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 10
Large-scale testing (Phase 3)Study completedNCT01971658
What this trial is testing

Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)

Who this might be right for
Multiple Myeloma
Nantes University Hospital 358
Testing effectiveness (Phase 2)Study completedNCT00772915
What this trial is testing

Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 39
Not applicableStudy completedNCT01508416
What this trial is testing

Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Centre Hospitalier Universitaire de Saint Etienne 71
Testing effectiveness (Phase 2)Looking for participantsNCT06793449
What this trial is testing

BCMA CAR-T Versus ASCT in Transplant-eligible Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 80
Not applicableUnknownNCT00166855
What this trial is testing

Clinical Implication of Bone Marrow Perfusion Patterns Imaged by Dynamic MRI in Multiple Myeloma

Who this might be right for
Multiple Myeloma, Newly Diagnosed
National Taiwan University Hospital 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06216158
What this trial is testing

Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Heidelberg Medical Center 411
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07601100
What this trial is testing

Isatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant Ineligible/Deferred Newly Diagnosed Myeloma

Who this might be right for
Newly Diagnosed Multiple Myeloma
Dana-Farber Cancer Institute 88
Testing effectiveness (Phase 2)Looking for participantsNCT05091372
What this trial is testing

Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Myeloma Multiple
M.D. Anderson Cancer Center 94
Post-approval studies (Phase 4)Study completedNCT01731886
What this trial is testing

Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Columbia University 60
Testing effectiveness (Phase 2)Study completedNCT00609167
What this trial is testing

Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 63
Testing effectiveness (Phase 2)Study completedNCT02237261
What this trial is testing

Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital Heidelberg 46
Large-scale testing (Phase 3)Study completedNCT03748953
What this trial is testing

Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Participants With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation (SCT)

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 37
Next Page